SEC Form SC 13G filed by Olink Holding AB
$OLK
Biotechnology: Laboratory Analytical Instruments
Industrials
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/5/2023 | $27.00 | Sector Outperform | Scotiabank |
| 12/14/2022 | $28.00 | Buy | Canaccord Genuity |
| 2/14/2022 | $33.00 → $32.00 | Equal-Weight | Morgan Stanley |
Scotiabank initiated coverage of Olink Holding with a rating of Sector Outperform and set a new price target of $27.00
Canaccord Genuity initiated coverage of Olink Holding with a rating of Buy and set a new price target of $28.00
Morgan Stanley reiterated coverage of Olink Holding with a rating of Equal-Weight and set a new price target of $32.00 from $33.00 previously